An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) will announce its first quarter 2024 financial results on May 1, 2024, with a conference call to follow. The event will be webcast live on the company's investor relations website.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) annuncerà i risultati finanziari del primo trimestre del 2024 il 1° maggio 2024, seguiti da una conferenza telefonica. L'evento sarà trasmesso in diretta via web sul sito web delle relazioni con gli investitori della società.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) anunciará sus resultados financieros del primer trimestre de 2024 el 1 de mayo de 2024, seguido de una conferencia telefónica. El evento se transmitirá en vivo en el sitio web de relaciones con inversores de la compañía.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT)는 2024년 5월 1일에 2024년 1분기 재무 결과를 발표할 예정이며, 이어서 컨퍼런스 콜이 진행될 것입니다. 이 행사는 회사의 투자자 관계 웹사이트에서 실시간 웹캐스트로 진행될 예정입니다.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) annoncera ses résultats financiers pour le premier trimestre 2024 le 1er mai 2024, suivis d'une conférence téléphonique. L'événement sera diffusé en direct sur le site web des relations avec les investisseurs de la société.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) wird am 1. Mai 2024 die Finanzergebnisse für das erste Quartal 2024 bekannt geben, gefolgt von einer Telefonkonferenz. Die Veranstaltung wird live auf der Website für Investorenbeziehungen des Unternehmens übertragen.
Positive
None.
Negative
None.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2024 financial results after the Nasdaq Global Market closes on Wednesday, May 1, 2024. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its first quarter 2024 financial results.
The event will be webcast live under the investor relations section of Sarepta's website at https://investorrelations.sarepta.com/events-presentations and following the event a replay will be archived there for one year. Interested parties participating by phone will need to register using this online form. After registering for dial-in details, all phone participants will receive an auto-generated e-mail containing a link to the dial-in number along with a personal PIN number to use to access the event by phone.
About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on LinkedIn, X (formerly Twitter), Instagram and Facebook.
Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website atwww.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.
When will Sarepta Therapeutics announce its first quarter 2024 financial results?
Sarepta Therapeutics will announce its first quarter 2024 financial results after the Nasdaq Global Market closes on Wednesday, May 1, 2024.
What is the ticker symbol for Sarepta Therapeutics?
The ticker symbol for Sarepta Therapeutics is SRPT.
Where can I access the live webcast of Sarepta Therapeutics' first quarter 2024 financial results event?
The live webcast of Sarepta Therapeutics' first quarter 2024 financial results event will be available on the investor relations section of Sarepta's website at https://investorrelations.sarepta.com/events-presentations.
How can I participate in the conference call discussing Sarepta Therapeutics' first quarter 2024 financial results?
Interested parties can participate in the conference call by registering through an online form on Sarepta Therapeutics' website to receive dial-in details and a personal PIN number to join by phone.
sarepta therapeutics is a biopharmaceutical company focused on the discovery and development of unique rna-targeted therapeutics for the treatment of rare, infectious and other diseases. the company is primarily focused on rapidly advancing the development of its potentially disease-modifying dmd drug candidates, including its lead dmd product candidate, eteplirsen, designed to skip exon 51. sarepta is also developing therapeutics for the treatment of infectious diseases, such as drug-resistant bacteria and other rare human diseases. for more information, please visit us at www.sarepta.com.
